scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M507762200 |
P698 | PubMed publication ID | 16179345 |
P50 | author | Stefan Offermanns | Q2337253 |
Denisa Wagner | Q30143521 | ||
Susan Wohler Sunnarborg | Q80172926 | ||
P2093 | author name string | David Lee | |
Wolfgang Bergmeier | |||
Barsom Aktas | |||
Bernhard Nieswandt | |||
Miroslava Pozgajova | |||
P2860 | cites work | Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V | Q24293698 |
The mechanism of action of aspirin | Q28165886 | ||
Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis | Q28165935 | ||
Structure-function relationship and role of tumor necrosis factor-alpha-converting enzyme in the down-regulation of L-selectin by non-steroidal anti-inflammatory drugs | Q28168180 | ||
Application of ex vivo flow chamber system for assessment of stent thrombosis | Q28193586 | ||
Parsing an enigma: the pharmacodynamics of aspirin resistance | Q28195015 | ||
A dual thrombin receptor system for platelet activation | Q28280578 | ||
Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen | Q28364081 | ||
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs | Q29617192 | ||
Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets | Q33349386 | ||
Aspirin. | Q33861695 | ||
Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition | Q34576477 | ||
Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity | Q34602844 | ||
Platelets in atherothrombosis | Q34986345 | ||
Acetylation of prostaglandin synthase by aspirin | Q35085661 | ||
Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice | Q36376147 | ||
The cytoplasmic domain of L-selectin participates in regulating L-selectin endoproteolysis | Q40790733 | ||
Salicylate- and aspirin-induced uncoupling of oxidative phosphorylation in mitochondria isolated from the mucosal membrane of the stomach | Q41064050 | ||
Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody | Q44063193 | ||
Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase | Q45016543 | ||
Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo | Q45042577 | ||
Distribution of the acetyl compared with the salicyl moiety of acetylsalicylic acid. Acetylation of macromolecules in organs wherein side-effects are manifest. | Q54080799 | ||
Membrane-anchored CD40 Is Processed by the Tumor Necrosis Factor-α-converting Enzyme | Q57372095 | ||
P433 | issue | 48 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | aspirin | Q18216 |
A disintegrin and metallopeptidase domain 17 | Q14907944 | ||
P304 | page(s) | 39716-22 | |
P577 | publication date | 2005-12-02 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Aspirin induces platelet receptor shedding via ADAM17 (TACE) | |
P478 | volume | 280 |
Q28543115 | A new ibuprofen derivative inhibits platelet aggregation and ROS mediated platelet apoptosis |
Q28542013 | Aspirin delimits platelet life span by proteasomal inhibition |
Q47626137 | Association of Oxidative Stress and Platelet Receptor Glycoprotein GPIbα and GPVI Shedding During Nonsurgical Bleeding in Heart Failure Patients With Continuous-Flow Left Ventricular Assist Device Support. |
Q43842035 | Changes in platelet GPIbα and ADAM17 during the acute stage of atherosclerotic ischemic stroke among Chinese |
Q34580886 | Circulating blood leukocyte gene expression profiles: effects of the Ames dwarf mutation on pathways related to immunity and inflammation |
Q28535234 | Combining aspirin with cholecalciferol (vitamin D3)--a potential new tool for controlling possum populations |
Q37781893 | Controversies in Oral Antiplatelet Therapy in Patients Undergoing Aortocoronary Bypass Surgery |
Q52864055 | GPVI modulation during platelet activation and storage: its expression levels and ectodomain shedding compared to markers of platelet storage lesion. |
Q92206236 | Ibrutinib, but not zanubrutinib, induces platelet receptor shedding of GPIb-IX-V complex and integrin αIIbβ3 in mice and humans |
Q43542406 | Inhibitory effects of Terminalia arjuna on platelet activation in vitro in healthy subjects and patients with coronary artery disease |
Q38874473 | Model systems for platelet receptor shedding |
Q24299819 | Nerve growth factor inhibits metalloproteinase-disintegrins and blocks ectodomain shedding of platelet glycoprotein VI |
Q43265578 | Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets |
Q33389665 | Proteolysis of platelet receptors in humans and other species |
Q38919547 | Regulation of platelet membrane protein shedding in health and disease |
Q57157303 | Reverse correlations of collagen-dependent platelet aggregation and adhesion with GPVI shedding during storage |
Q43263728 | Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibalpha shedding |
Q39268482 | The SLAM family member CD84 is regulated by ADAM10 and calpain in platelets |
Q39324569 | The production of soluble C-type lectin-like receptor 2 is a regulated process |
Q44232385 | The role of mitochondrial permeability transition pore in regulating the shedding of the platelet GPIbα ectodomain |
Search more.